ATE182470T1 - Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung - Google Patents
Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzungInfo
- Publication number
- ATE182470T1 ATE182470T1 AT94928519T AT94928519T ATE182470T1 AT E182470 T1 ATE182470 T1 AT E182470T1 AT 94928519 T AT94928519 T AT 94928519T AT 94928519 T AT94928519 T AT 94928519T AT E182470 T1 ATE182470 T1 AT E182470T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- lactalbumin
- antibacterial composition
- containing antibacterial
- influenzae
- Prior art date
Links
- 102000004407 Lactalbumin Human genes 0.000 title abstract 3
- 108090000942 Lactalbumin Proteins 0.000 title abstract 3
- 235000021241 α-lactalbumin Nutrition 0.000 title abstract 3
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 241000606768 Haemophilus influenzae Species 0.000 abstract 2
- 102000007474 Multiprotein Complexes Human genes 0.000 abstract 2
- 108010085220 Multiprotein Complexes Proteins 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 210000002345 respiratory system Anatomy 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
- A23J3/10—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/24—Extraction; Separation; Purification by electrochemical means
- C07K1/26—Electrophoresis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Electrochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/SE1994/000742 WO1996004929A1 (en) | 1994-08-16 | 1994-08-16 | Antibacterial composition containing multimeric alpha-lactalbumin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE182470T1 true ATE182470T1 (de) | 1999-08-15 |
Family
ID=20393168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94928519T ATE182470T1 (de) | 1994-08-16 | 1994-08-16 | Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6599874B1 (de) |
| EP (1) | EP0776214B1 (de) |
| JP (1) | JP3694319B2 (de) |
| AT (1) | ATE182470T1 (de) |
| AU (1) | AU7792294A (de) |
| CA (1) | CA2197659C (de) |
| DE (1) | DE69419782T2 (de) |
| DK (1) | DK0776214T3 (de) |
| ES (1) | ES2136206T3 (de) |
| GR (1) | GR3031078T3 (de) |
| WO (1) | WO1996004929A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968901A (en) * | 1989-10-30 | 1999-10-19 | Andersson; Bengt | Antibacterial composition |
| GB9724725D0 (en) * | 1997-11-21 | 1998-01-21 | Svanborg Catharina | Protein production process |
| ES2286860T3 (es) * | 1997-11-21 | 2007-12-01 | Nya Hamlet Pharma Ab | Proceso de produccion de lactoalbumina. |
| GB9725126D0 (en) | 1997-11-27 | 1998-01-28 | Svanborg Catharina | Therapeutic agents |
| DE60040856D1 (de) * | 1999-07-28 | 2009-01-02 | Morinaga Milk Industry Co Ltd | Lactalbumin zur kurativen Behandlung von Magengeschwüren |
| EP1427436B1 (de) * | 2001-08-23 | 2008-07-02 | Westgate Biological Limited | Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen |
| GB0210464D0 (en) | 2002-05-08 | 2002-06-12 | Svanborg Catharina | Therapeutic treatment |
| CN102590413B (zh) * | 2012-01-18 | 2013-12-25 | 浙江省疾病预防控制中心 | 一种牛α-乳白蛋白的定量检测方法 |
| WO2014023976A1 (en) | 2012-08-09 | 2014-02-13 | Hamlet Pharma Ab | Prophylactic and nutraceutical therapy |
| WO2024075003A1 (en) | 2022-10-03 | 2024-04-11 | Linnane Pharma Ab | A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer |
| GB202303177D0 (en) | 2023-03-03 | 2023-04-19 | Linnane Pharma Ab | Method of predicting response to treatment |
| WO2025186107A1 (en) | 2024-03-04 | 2025-09-12 | Linnane Pharma Ab | Therapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2459619B1 (fr) * | 1979-06-26 | 1983-07-29 | Agronomique Inst Nat Rech | Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede |
| EP0058665B1 (de) | 1980-05-09 | 1986-02-26 | LEFFLER, Hakon | Carbohydrat-derivate zum hemmen eines bakteriellen anhaftens |
| CA1333471C (en) * | 1988-04-29 | 1994-12-13 | Gustavo Bounous | Whey protein concentrate as food supplement |
| US5968901A (en) * | 1989-10-30 | 1999-10-19 | Andersson; Bengt | Antibacterial composition |
| US5795611A (en) | 1989-12-20 | 1998-08-18 | Slattery; Charles W. | Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein |
| JP2961625B2 (ja) * | 1991-01-21 | 1999-10-12 | 雪印乳業株式会社 | α−ラクトアルブミン含有量の高い組成物の製造方法 |
-
1994
- 1994-08-16 WO PCT/SE1994/000742 patent/WO1996004929A1/en not_active Ceased
- 1994-08-16 DK DK94928519T patent/DK0776214T3/da active
- 1994-08-16 EP EP94928519A patent/EP0776214B1/de not_active Expired - Lifetime
- 1994-08-16 JP JP50722496A patent/JP3694319B2/ja not_active Expired - Lifetime
- 1994-08-16 DE DE69419782T patent/DE69419782T2/de not_active Expired - Lifetime
- 1994-08-16 AU AU77922/94A patent/AU7792294A/en not_active Abandoned
- 1994-08-16 AT AT94928519T patent/ATE182470T1/de not_active IP Right Cessation
- 1994-08-16 ES ES94928519T patent/ES2136206T3/es not_active Expired - Lifetime
- 1994-08-16 CA CA002197659A patent/CA2197659C/en not_active Expired - Fee Related
-
1999
- 1999-08-26 GR GR990402161T patent/GR3031078T3/el unknown
-
2000
- 2000-08-17 US US09/639,938 patent/US6599874B1/en not_active Expired - Fee Related
-
2003
- 2003-07-11 US US10/617,093 patent/US7144855B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0776214A1 (de) | 1997-06-04 |
| EP0776214B1 (de) | 1999-07-28 |
| US6599874B1 (en) | 2003-07-29 |
| DK0776214T3 (da) | 1999-11-29 |
| US7144855B2 (en) | 2006-12-05 |
| US20040106541A1 (en) | 2004-06-03 |
| DE69419782D1 (de) | 1999-09-02 |
| DE69419782T2 (de) | 1999-12-23 |
| JPH10504547A (ja) | 1998-05-06 |
| ES2136206T3 (es) | 1999-11-16 |
| CA2197659C (en) | 2009-11-10 |
| GR3031078T3 (en) | 1999-12-31 |
| CA2197659A1 (en) | 1996-02-22 |
| WO1996004929A1 (en) | 1996-02-22 |
| AU7792294A (en) | 1996-03-07 |
| JP3694319B2 (ja) | 2005-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU563748B2 (en) | Quinolone carboxylic acids | |
| DE69430823D1 (de) | Verfahren zur behandlung von gram-negativen bakterien infektion durch verabreichung von bakterientötendem/durchlässigkeiterhöhendem (bpi) proteinprodukt und antibiotikum | |
| CA2189658A1 (en) | Controlled-Release Dosage Forms of Azithromycin | |
| DK0776214T3 (da) | Antibakterialt præparat indeholdende multimert alfa-lactalbumin | |
| DE59710183D1 (de) | Topische mittel zur prophylaxe oder behandlung bakterieller hautinfektionen | |
| IL156942A0 (en) | Compounds, pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia | |
| EE200000587A (et) | Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis | |
| DE60001687D1 (de) | Trovafloxacin enhaltende Suspensionen zur oralen Anwendung | |
| WO2000058475A3 (en) | Streptococcus pneumoniae antigens | |
| TR199900661T2 (xx) | Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m� | |
| KR880701734A (ko) | 글리코 펩티드 항생물질 | |
| DE69914911D1 (de) | Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen | |
| NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
| SE8903625D0 (sv) | Antibacterial composition | |
| DK577181A (da) | Polypeptidfraktioner fra muslinger | |
| CLARKE | TOPICAL USE OF SILVER SULPHADIAZINE AND CHLORHEXIDINE IN THW PREVENTION OF INFECTION IN THERMAL INJURIES | |
| DE69739775D1 (de) | Verabreichung von Produkten des 5-lipoxygenase Synthesewegs zur Behandlung von mikrobiellen Infektionen | |
| Ginsburg | Streptococcus. | |
| WO2001096381A3 (en) | IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION | |
| WO2002000839A3 (en) | Statement as to federally sponsored research | |
| WO1998021231A3 (en) | Streptococcus uberis lactoferrin-binding protein | |
| Scatizzi et al. | Prevention of Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis | |
| McDougall | Burns and the Use of Silver Sulphadiazine 1 | |
| FR2307542A1 (fr) | Nouvelle preparation immunostimulante | |
| Lechi et al. | Clinical evaluation of ceftazidime in the treatment of infections caused by Pseudomonas and other gram-negative bacteria. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |